In this excellent review of acute promyelocytic leukemia (APL) treatment, the authors highlight opportunities offered by incorporating arsenic trioxide (ATO) into the therapeutic armamentarium.
Miguel A. Sanz, MD, PhD
Advertisement
Articles by Miguel A. Sanz, MD, PhD
Advertisement
Latest Updated Articles
- Arsenic Trioxide in the Management of APL: Proceed With Caution
Published: July 11th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
3
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
4
BL-B01D1 Shows Preliminary Efficacy, Favorable Safety in Urothelial Cancer
5
